ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Redo Surgical Aortic Valve Replacement for Bioprosthetic Structural Valve Deterioration

Thursday, January 23, 2025

Submitted by

EACTS Staff

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Source URL: https://academic.oup.com/ejcts/article-abstract/66/4/ezae353/7789472?redirectedF…

Author(s)

Matthias Raschpichler, Philip Kiefer, Wolfgang Otto, Thilo Noack, Maria Gerber, Suzanne De Waha, Alexey Dashkevich, Sergey Leontyev, Martin Misfeld, Michael A Borger

This study compared isolated primary bioprosthetic surgical aortic valve replacement (SAVR) with isolated redo surgical aortic valve replacement (rSAVR) due to structural valve deterioration (SVD). The study used clinical data from consecutive patients who underwent primary isolated SAVR and isolated rSAVR due to SVD between 1 January 2011 and 31 December 2022. A total of 2,620 patients, with 39.5 percent females, were included, and rSAVR was performed in 174 patients (6.6 percent). In a matched comparison of 322 patients, the rates of death or stroke did not differ between the groups. Therefore, patients undergoing rSAVR on an elective basis can expect outcomes similar to those of primary SAVR.